How FDA Classification Determines Your Cap Table
Not regulatory training — structural consequence analysis. How 510(k) vs. PMA vs. IND-to-NDA pathways determine capital requirements, funding round count, dilution trajectory, and founder equity at exit. How acquirers price regulatory risk into deal terms.
This evolution is under development. Content will be available when the next cohort begins.